Enveric Biosciences, Inc.

NASDAQ (USD): Enveric Biosciences, Inc. (ENVB)

Last Price

0.47

Today's Change

-0.001 (0.21%)

Day's Change

0.453 - 0.49

Trading Volume

309,949

Overview

Market Cap

3 Million

Shares Outstanding

7 Million

Avg Volume

578,409

Avg Price (50 Days)

0.66

Avg Price (200 Days)

1.11

PE Ratio

-0.07

EPS

-6.39

Earnings Announcement

12-Aug-2024

Previous Close

0.47

Open

0.48

Day's Range

0.453 - 0.4899

Year Range

0.41 - 3.898

Trading Volume

309,949

Price Change Highlight

1 Day Change

-0.15%

5 Day Change

-9.56%

1 Month Change

-25.30%

3 Month Change

-47.45%

6 Month Change

-47.60%

Ytd Change

-62.67%

1 Year Change

-81.41%

3 Year Change

-99.49%

5 Year Change

-99.97%

10 Year Change

-99.99%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment